We strive to make nucleoside and nucleotide analog production easier, cheaper and more sustainable!
BioNukleo develops new (chemo-) enzymatic synthesis routes for nucleic acid derivatives. Due to our strong competence in the expression of challenging proteins, we have set up enzyme libraries with wide substrate promiscuity. They allow for the production of a broad range of nucleoside and nucleotide analogs. Together with partners we develop processes up to the industrial scale.
Imprint
http://www.bionukleo.com/imprint-1
Company Details
- Employees
- 4
- Founded
- -
- Address
- Ackerstrasse 76, Berlin,berlin 13355,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bionukleo.com
- Keywords
- nucleic acid derivatives, bioprocess development, nucleoside analogs, nucleotide analogs, thermostable enzymes, sugar-1-phosphates.
- HQ
- Berlin, Berlin
Bionukleo Questions
Bionukleo's website is bionukleo.com
Bionukleo's LinkedIn profile is https://de.linkedin.com/company/bionukleo
Bionukleo has
4 employees.
View email and phone details for 4
employees at Bionukleo.
Bionukleo's industry is
Biotechnology Research
Bionukleo's top competitors are
Bio-Pat E.v.,
Animox Gmbh,
Kiwi-Biolab,
Celltainer Biosolutions Gmbh,
Abitep Gmbh,
Knauer,
Bioprocess Engineering-Tu Berlin,
Enpresso Gmbh,
Probiogen Ag,
Cell4chem.
Bionukleo's categories are Biotechnology Research
Bionukleo's founding year is 2014
